Attend the FierceBiotech Executive Breakfast at BIO 2019
Join us on June 5th for our panel discussion on real-world evidence. Reserve your seat today.
Duke engineers have devised a short tail that's added to the guide RNA used in gene editing systems and that locks when it reaches its target.
Scientists at Boston Children's and MIT built CAR-T cells that are inspired by alpaca antibodies and can target protective proteins around solid tumors.
By studying Ebola survivors' immune responses, scientists have gained new insights that could improve vaccine development.
With the help of CRISPR, two separate team of scientists have identified a gene essential for the survival of microsatellite instability tumors.
Injecting a vaccine into tumor sites produced remissions in mice and some lymphoma patients in a study at Mount Sinai.
Allergan's experimental antidepressant rapastinel holds promise for opioid withdrawal symptoms, two scientists have found.
Two research groups have uncovered clues to immuno-oncology drug resistance, offering insight that could lead to new treatment strategies.
Inhibiting CD22 may help treat or prevent neurodegenerative diseases by restoring the brain's microglia, a Stanford team found.
The week’s biotech discoveries included an I-O triple therapy against ovarian cancer and a single protein target for three diseases.
A CD40-activating antibody combined with BMS's Opdivo and chemo shrunk tumors in 20 out of 24 patients with pancreatic cancer.
